Efficacy and safety of levodopa–carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson’s disease patients

In a previous multinational, randomized, double-blind, double-dummy study, levodopa–carbidopa intestinal gel (LCIG) was tolerable and significantly improved ‘off’ time in advanced Parkinson’s disease (PD) patients. However, efficacy and safety in the Asian population has not yet been demonstrated. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Miho, Mihara, Masahito, Hasegawa, Kazuko, Jeon, Beomseok, Tsai, Chon-Haw, Nishikawa, Noriko, Oeda, Tomoko, Yokoyama, Masayuki, Robieson, Weining Z, Ryman, Davis, Eaton, Susan, Chatamra, Krai, Benesh, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516619/
https://www.ncbi.nlm.nih.gov/pubmed/28725701
http://dx.doi.org/10.1038/npjparkd.2016.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516619/
https://www.ncbi.nlm.nih.gov/pubmed/28725701
http://dx.doi.org/10.1038/npjparkd.2016.20

Ejemplares similares